This inventor holds 1 USPTO granted patent. Top assignee: Best Theratronics Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Toby Henderson
Introduction
Toby Henderson is a notable inventor based in Rockford, IL (US). He has made significant strides in the field of medical technology, particularly in cancer treatment. His work focuses on the development of advanced cyclotron technology aimed at improving patient care.
Latest Patents
Henderson holds a patent for a 70 MeV to 150 MeV cyclotron dedicated to medical treatment, which includes a robotic chair/table. This proton cyclotron is specifically designed for treating head, neck, and eye cancers, as well as other medical conditions, including pediatric cancers. The method involves positioning the patient on a support platform, such as a patient table or robotic chair, and using a proton particle beam from the cyclotron to irradiate the tumor or cancer for a predetermined time. The energy range of the proton particle beam is between 70 MeV and 150 MeV, with a beam current suitable for radiation therapy.
Career Highlights
Henderson's career is marked by his innovative approach to medical technology. His work at Best Theratronics Ltd. has positioned him as a key player in the development of advanced treatment options for cancer patients. His patent reflects his commitment to enhancing the efficacy of cancer treatments through technological advancements.
Collaborations
Henderson has collaborated with notable colleagues, including Richard Ray Johnson and Leandro Piazza. These partnerships have contributed to the successful development and implementation of his innovative technologies.
Conclusion
Toby Henderson's contributions to medical technology, particularly through his patented cyclotron, demonstrate his dedication to improving cancer treatment. His work continues to impact the field positively, offering hope for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile